Document:

Release Agreement

 Exhibit 10.30 
 RELEASE AGREEMENT AND CONTRACTUAL UNDERTAKINGS 
 This agreement (the “Agreement”) is
entered into by and between the following parties (the “Parties”): (i) David H. Brooks (“Mr. Brooks”) and (ii) DHB Industries, Inc. (the “Company” or “DHB”). 
 RECITALS 
 On July 12,
2006, the Company and Mr. Brooks, among others, entered into a Memorandum of Understanding (“MOU”) regarding the settlement of the matters captioned (i) In re DHB Industries, Inc. Class Action Litigation, United States
District Court for the Eastern District of New York, No. CV 05-4296 (JS) (ETB) and (ii) In re DHB Industries, Inc. Derivative Litigation, United States District Court for the Eastern District of New York, CV 05-4345 (JS) (ETB)
(collectively, the “Litigation”). 
 The MOU requires the Parties to execute various agreements relating to the settlement of the
Litigation and other matters, to take certain actions, and to exchange general releases as provided in the MOU. 
 Pursuant to the MOU, the
Parties are executing simultaneously herewith the following agreements: (i) Securities Purchase Agreement (Exhibit A); (ii) Registration Rights Agreement (Exhibit B); (iii) Warrant Exercise Agreement (Exhibit C); (iv) Escrow
Agreement (Exhibit D); (v) Undertaking (Exhibit E); and Agreement Among Insureds (Exhibit F). In addition, the Parties are in the process of preparing additional agreements required to be executed pursuant to the MOU, including Stipulations of
Settlement of the Litigation and various releases. The MOU, the Securities Purchase Agreement, the Registration Rights Agreement, the Warrant Exercise Agreement, the Escrow Agreement, the Undertaking, the Agreement Among Insureds, and other
agreements between the Parties required to be executed under the terms of the MOU are referred to herein as the “Operative Agreements.” Each of the Operative Agreements memorializes and details rights and obligations created by the MOU
with respect to the subject matter of each agreement. 
 This Agreement is being entered into to effectuate, memorialize, and detail
additional terms of the MOU, including the obligation of the Parties to exchange releases in the form specified in the MOU and the obligation of Mr. Brooks to resign from the Board of Directors of DHB and from all of the other positions held by
him in DHB. 
 AGREEMENT 
 In consideration of the mutual obligations set forth in the Operative Agreements and in this Agreement, the Parties agree as follows: 
  

	 	1.	 Effect on Other Agreements. With the exception of the Operative Agreements, which remain in full force and effect except to the extent that they conflict
with this Agreement, this Agreement supersedes and rescinds all prior agreements (“Prior Agreements”) between DHB and Mr. Brooks, whether verbal or in writing, 

	 	 
including but not limited to: (i) the employment agreement between DHB and Mr. Brooks dated July 1, 2000, as extended by Mr. Brooks
through June 30, 2010; (ii) the Warrant Agreement between DHB and Mr. Brooks dated July 1, 2005; and (iii) any contract rights created by prior resolutions of the Board of Directors of DHB with respect to reimbursement of
costs or expenses incurred by Mr. Brooks for travel, entertainment or housing. All Prior Agreements are hereby terminated, and Mr. Brooks shall have no further rights to compensation including any severance thereunder. Notwithstanding the
foregoing, this Agreement shall not affect any rights of Mr. Brooks arising solely from (i) ownership or control of securities issued by DHB or (ii) options and/or warrants previously granted to Mr. Brooks on the same terms and
conditions as other directors as compensation for service on the Board of Directors of the Company (which options and/or warrants shall remain valid and enforceable). 

  

	 	2.	Best Efforts. Each of DHB and Mr. Brooks represents and warrants that each shall use reasonable best efforts in all respects to consummate and secure judicial approval
of the settlements contemplated by the MOU, including prompt preparation of all settlement documents and diligent advocacy of the settlements at all stages of court and appellate proceedings. 

  

	 	3.	Resignation of Mr. Brooks. By executing this Agreement, Mr. Brooks hereby resigns from the Board of Directors of DHB and from all of the other positions held by him
in DHB or any of its subsidiaries or affiliates. Mr. Brooks represents and warrants that his resignation is entirely voluntary and entered into solely in consideration of the representations and agreements set forth in this Agreement, other
agreements entered into simultaneously herewith, and the MOU. DHB shall promptly pay Mr. Brooks, on a pro rata basis through the date of execution of this Agreement, any unpaid salary at the pre-existing rate of $800,000 per year.
Mr. Brooks shall not be entitled to any unpaid bonus, DHB warrants not yet awarded, accrued or unused vacation, or unpaid expenses. Mr. Brooks shall be eligible for continued coverage under DHB-sponsored health and dental plans to the
extent permitted by the Consolidated Omnibus Budget Reconciliation Act of 1985, and the Company shall provide Mr. Brooks with such information and forms as are required for him to exercise this right. The Company shall permit Mr. Brooks a
reasonable opportunity to remove all personal items from offices of DHB and its subsidiaries, including but not limited to model ships, model cars, and the like. 

  

	 	4.	Board and Committee Minutes. DHB shall provide Mr. Brooks with the minutes of any meetings of the Board of Directors of DHB or committees thereof for the three months
prior to the date of execution of this Agreement within a reasonable time following DHB’s completion and approval of such minutes. 

  

	 	5.	 Personal Guarantees of Mr. Brooks and his Spouse. Upon the execution of this Agreement, Mr. Brooks will identify any and all obligations of which
he is aware that were incurred solely for the benefit and in the name of DHB in the ordinary course of business, not in violation of any statute, regulatory or other legal obligations and not contrary to any resolution or direction of the Board of
Directors or 

  

 Page 2 

	 	 
the Company’s policies (excluding any such obligations that directly benefited Mr. Brooks, his spouse or Mr. Brooks’ family members), and
that are subject to personal guarantees by Mr. Brooks and/or his spouse (“Obligations”). Mr. Brooks represents that, to the best of his present recollection, the sole Obligations are guarantees by Mr. Brooks of certain DHB
American Express credit cards, with debit balances not believed to have exceeded $50,000 when last known to Mr. Brooks, and his guarantee of accounts payable by DHB to Hexcel Corporation. Within 60 days of the execution of this Agreement (with
respect to obligations to Hexcel and American Express referenced in this Agreement) and Mr. Brooks’ identification of such Obligations (with respect to any other Obligations), the Company shall either (i) pay such Obligations; or
(ii) secure from the relevant persons a release of the relevant guarantees by Mr. Brooks and/or his spouse. 

  

	 	6.	DHB’s New York Office Lease. If by August 31, 2006, the Company secures the required consent of the landlord of the space occupied by DHB’s New York Office and
delivers the space to Mr. Brooks, (i) Mr. Brooks shall accept assignment of such lease and assume all future obligations of DHB under the presently operative lease for such space with no further obligations under the lease accruing to
DHB after the date of assignment; and (ii) except as otherwise provided in Paragraph 7 of this Agreement, the Company shall transfer to Mr. Brooks at no charge all furniture and equipment of DHB now contained in the New York Office. If the
foregoing conditions are not met by August 31, 2006, Mr. Brooks shall have no rights or obligations with respect to the lease or the furniture and equipment of DHB contained in the New York Office, and shall immediately thereafter vacate
the New York Office. 

  

	 	7.	Return of Company Property by Mr. Books. Except as otherwise provided in this Agreement or the Operative Agreements, Mr. Brooks shall return to DHB all property and
equipment owned by DHB presently in Mr. Brooks’ possession, custody or control, including, without limitation, any computers or software, credit cards of DHB, any rights to a Madison Square Garden (“MSG”) skybox or any other
Company-owned seats or Company-owned tickets to MSG or other sporting or entertainment venues. 

  

	 	8.	Indemnification and Advancement of Attorneys’ Fees and Expenses. Confirming his earlier undertaking, Mr. Brooks has executed the undertaking attached as Exhibit E.
Mr. Brooks shall cause his personal counsel Milbank Tweed and Mintz Levin promptly to pay to the Company any unused legal fees or retainer above $100,000 that has not been expended or incurred as of August 14, 2006. After receiving such
unused retainer or legal fees, the Company thereafter shall promptly indemnify and advance the fees and expenses of Mr. Brooks’ counsel to the maximum extent allowed by DHB’s Articles of Incorporation and By-Laws and the laws of the
State of Delaware (the “Indemnification and Advancement Rights”). Mr. Brooks agrees to cause his counsel to present a bill for their fees and expenses on a monthly basis. The Company agrees to pay Mr. Brooks’ counsel all
reasonable fees and expenses within 30 days of the presentation of such bills, net of application of the $100,000 amount for each firm. 

  

 Page 3 

	 	9.	General Release of DHB. Except for claims arising from this Agreement or the Operative Agreements, DHB, on behalf of itself and its past and present predecessors, successors,
parents, affiliates, divisions, directors, officers and employees, and subsidiaries (collectively, the “DHB Releasors”), does hereby and forever release David H. Brooks from any and all claims, demands, causes of action or suits, costs,
expenses or compensation for or on account of any damages, liability, loss or injury, whether known or unknown, that the DHB Releasors ever had, now have or hereafter can, shall, or may have from the beginning of time to the day of the date of this
Agreement, including, without limitation, any and all claims relating to the Litigation. 

  

	 	10.	General Release of Mr. Brooks. Except for claims arising from this Agreement, the Operative Agreements, the Indemnification and Advancement Rights, or claims arising
after the date of execution of this Agreement solely from his ownership of DHB securities, David H. Brooks does hereby and forever release the DHB Releasors from any and all claims, demands, causes of action or suits, costs, expenses or compensation
for or on account of any damages, liability, loss or injury, whether known or unknown, that he ever had, now have or hereafter can, shall, or may have from the beginning of time to the day of the date of this Agreement, including, without
limitation, any and all claims relating to the Litigation. 

  

	 	11.	Effectiveness of General Releases. Upon execution of this Agreement, the general releases set forth in paragraph 9 and 10 above shall be immediately valid and enforceable.
However, in the event that the Settlement on the same material terms as referred to in the MOU is not approved by the Court or otherwise does not become effective despite the reasonable best efforts of the Parties (“Ineffective Date”),
such releases shall become null and void. 

  

	 	12.	Tolling of Statute of Limitation. Any applicable statutes of limitation with respect to any claims subject to the releases set forth in paragraphs 9 and 10 that DHB may have
against Mr. Brooks, or that Mr. Brooks may have against DHB, are hereby tolled from the date as of which this agreement was made until July 28, 2008, (“Tolling Period”), and no defense to any such claim may be asserted or
raised against or by either party against the other based on the passage of time, including, without limitation, statute of limitations, laches, waiver or estoppel, to the extent such defense is based on the passage of time during the Tolling
Period. 

  

	 	13.	Registration of Stock Underlying Outstanding Warrants/Options. The Company shall register common stock underlying options and/or warrants granted to Mr. Brooks for
service as a director of the Company at the same time and on the same terms and conditions as the Company registers common stock underlying any options and/or warrants concurrently granted to other directors for the same term of service on the Board
of Directors. 

  

 Page 4 

	 	14.	Confidential Information. 

  

	 	(a)	Mr. Brooks hereby acknowledges that during his employment at DHB, he acquired confidential information (“Confidential Information,” as defined and described in this
sub-paragraph). Confidential Information shall mean all non-public information, whether or not created or maintained in written or electronic form, which constitutes, relates or refers to the Company, any current or former employees of the Company,
any aspect of the operation of the business of the Company, including without limitation, all financial, operational and statistical information, or any information or documents protected and/or governed by the attorney-client privilege, work
product immunity or any similar privilege or immunity. 

  

	 	(b)	Mr. Brooks hereby represents and agrees that upon execution of this Agreement that he: (i) has returned to the Company all original or non-duplicate documents, records or
materials of any kind, whether written or electronically created or stored, which contain, relate to or refer to any Confidential Information (“Confidential Materials”); (ii) has not disclosed any Confidential Information or
Confidential Materials to any person or entity, except to his attorneys and persons assisting them in legal representation, since July 7, 2006; and (iii) shall not disclose any Confidential Information or Confidential Materials, in any
manner directly or indirectly, except (a) as shall be required by law, (b) to government officials in the course of official investigation or proceedings, (c) to his attorneys or persons assisting them solely for use in connection
with legal representation, or (d) upon the Company’s written consent. In the event that Mr. Brooks receives a subpoena or any other written or oral request for any Confidential Information or Confidential Materials from any person
other than a government official acting in an official capacity, he shall provide the Company with reasonable notice and opportunity to oppose such request before producing any such Confidential Information or Confidential Materials in response to
such subpoena or other request. Mr. Brooks shall provide such notice to the Company in writing, by fax to Kenneth Henderson, Esq. Bryan Cave, LLP, 1290 Avenue of the Americas, New York, New York 10104, Fax: (212) 541-4630, provide a
copy of such subpoena or other request if in writing, and/or disclose the nature of the request for information if oral. 

  

	 	15.	Non-Competition and Non-Solicitation. 

  

	 	(a)	 Mr. Brooks will not for a period of twelve months subsequent to his termination of employment (the “Restricted Period”), either as an individual, or
in conjunction with any other person, firm, corporation, or other entity, whether acting as a principal, agent, consultant, or in any capacity whatsoever, including without limitation through Tactical Armor Products, Inc. (“TAP”):
(i) render any services in the capacity as an executive, manager, supervisor, employee, independent contractor or consultant within the Defined 

  

 Page 5 

	 	 
Geographic Area (as defined herein) to any person, firm, corporation or other entity engaged in any Competitive Business; (ii) engage in any Competitive
Business within the Defined Geographic Area for Mr. Brooks’ own account; or (iii) become a partner, shareholder, member, investor or otherwise own any interest in a Competitive Business in the Defined Geographic Area;
(iv) solicit, attempt to solicit or communicate in any way with DHB’s customers for the purpose of soliciting business away from DHB for a Competitive Business; or (v) solicit, attempt to solicit, or communicate in any way with any
employees or consultants of the Company or its affiliates, other than Teddy Tawil and members of Mr. Brooks’ family, for the purpose of having such employees cease being employed or to become employed or in any way engaged by another
person, firm, corporation, or other entity. 

  

	 	(b)	For purposes of this Agreement, a “Competitive Business” shall mean any company that engages in the design, manufacture, sale or distribution of protective body
armor or athletic supports or braces. 

  

	 	(c)	For purposes of this Agreement, “Defined Geographic Area” shall mean the United States and any foreign countries in which DHB has done business.

  

	 	(d)	Mr. Brooks acknowledges and agrees the limitations as to time, geographical area and scope of activity to be restrained by this Section are reasonable and acceptable to him,
and do not impose any greater restraint than is reasonably necessary to protect the goodwill and other business interests of the Company. Mr. Brooks further agrees that his performance of the covenants and agreements contained herein, and the
enforcement by the Company of the provisions contained herein, will cause no undue hardship on him. 

  

	 	(e)	Mr. Brooks may make a written request to the Company, before undertaking any of the activities described in this Section, to be allowed to engage in such activities during the
Restricted Period. The Company may, in its sole and absolute discretion, either grant or withhold permission to engage in the requested activity. In no event will the Company grant permission if Mr. Brooks has engaged in any activity that
violates this Section before seeking the Company’s consent. Mr. Brooks may not rely on any authorization granted pursuant to this paragraph unless it is in writing and signed by a duly authorized officer of the Company.

  

	 	16.	Irreparable Harm. Due to the irreparable and continuing nature of the injury which would result from a breach of the covenants, as described in paragraphs 14 and 15 above,
Mr. Brooks agrees that the Company may, in addition to any remedy which it may have at law or in equity, apply to any court of competent jurisdiction for the entry of an immediate order to restrain or enjoin the breach of these covenants and to
otherwise specifically enforce the provisions of this covenant, and Mr. Brooks waives any requirement on the part of the Company to post a bond with respect to such application. 

  

 Page 6 

	 	17.	Miscellaneous. 

  

	 	(a)	This Agreement may be executed in counterparts. 

  

	 	(b)	No negative inference of interpretation shall be made by a court against any party to this Agreement. 

  

	 	(c)	This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to its choice of law rules. 

  

	 	(d)	The terms and conditions of this Agreement, including the mutual releases contained in this Agreement, shall inure to the benefit of and be binding upon the respective successors,
heirs, estates, and assigns of the Parties. 

  

	 	(e)	DHB represents that this Agreement was authorized in the manner required by applicable law and the governing articles of incorporation and bylaws. 

  

	 	(f)	Mr. Brooks represents, warrants and covenants that he has paid or shall pay all taxes (including without limitation federal and state, Social Security, Medicare, FICA or other
withholding taxes or similar amounts) attributable to personal income received by him from the Company, including any fines, penalties or back taxes incurred by the Company solely as a result of personal income paid to Mr. Brooks.

  

 Page 7 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the day and year first
above written. 
 Dated: July 31, 2006 
  

			
	DHB INDUSTRIES, INC.
		
	By:	 	  

	
	DAVID H. BROOKS
	
	  

  

 Page 8Securities Purchase Agreement

 Exhibit 10.31 
 EXECUTION COPY 
 SECURITIES PURCHASE AGREEMENT 
 This Securities Purchase Agreement (this “Agreement”) is dated as of July 31, 2006, between DHB Industries, Inc., a Delaware
corporation (the “Company”), and David H. Brooks, an individual residing at 20 Red Ground Road, Old Westbury, New York 11568 (the “Investor”). 
 WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act (as defined below) and
Rule 506 promulgated thereunder, the Company desires to issue and sell to the Investor, and the Investor desires to purchase from the Company certain securities of the Company, as more fully described in this Agreement. 
 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Investor agree as follows: 
 ARTICLE 1. 
 DEFINITIONS 
 1.1. Definitions. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings indicated in this Section 1.1: 
 “Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with such specified Person, as such terms are used in and construed under Rule 144. 
 “Business Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions in the State of New York or State of Oregon are authorized or required by law or other
governmental action to close. 
 “Closing” means the closing of the purchase and sale of the Shares pursuant to
Article II. 
 “Closing Date” means the date hereof, or such other date as the parties may agree. 
 “Commission” means the Securities and Exchange Commission. 
 “Common Stock” means the common stock of the Company, $0.001 par value per share, and any securities into which such common stock may
hereafter be reclassified or changed into. 
 “Company Deliverables” has the meaning set forth in Section 2.2(a).

 “Compliance Date” means the date on which the Company first comes into compliance with
its periodic filing requirements under the Commission’s rules and regulations, including the Exchange Act. 
 “Exchange
Act” means the Securities Exchange Act of 1934, as amended. 
 “Investment Amount” means $14,825,000. 

“Investor Deliverables” has the meaning set forth in Section 2.2(b). 
 “Lien” means any lien, charge, encumbrance, security interest, pledge, mortgage, right of first refusal or other restrictions of any
kind. 
 “Material Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or
enforceability of any Transaction Document, or (ii) a material and adverse effect on the results of operations, assets, prospects, business or condition (financial or otherwise) of the Company. 
 “MOU” has the meaning set forth in Section 4.3. 
 “New York Courts” means the United States District Court for the Eastern District of New York, before the Honorable Joanna Seybert, if available, or if not available, before another judge in either
the Eastern or Southern District of New York; provided, however, that if the Eastern and Southern District of New York both lack subject matter jurisdiction over a claim or dispute, then with respect to such claim or dispute, the term “New York
Courts” shall mean the Supreme Court of the State of New York in the County of New York. 
 “Per Share Purchase Price”
equals $4.93. 
 “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 “Registration Rights Agreement” means the Registration Rights Agreement, dated as of the date of this Agreement, among
the Company and the Investor, in the form of Exhibit A hereto. 
 “Registration Statement” means a registration
statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the Investor of the Shares. 
 “Rejection Date” has the meaning set forth in Section 4.3. 
  

 2 

 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act,
as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Securities Act” means the Securities Act of 1933, as amended. 
 “Shares”
means the shares of Common Stock issued or issuable to the Investor pursuant to this Agreement. 
 “Short Sales” include,
without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps and similar
arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers. 
 “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market, or (ii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the
over-the-counter market as reported by the Pink Sheets, LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in
(i) and (ii) hereof, then Trading Day shall mean a Business Day. 
 “Trading Market” means whichever of the New
York Stock Exchange, the American Stock Exchange, the NASDAQ National Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 
 “Transaction Documents” means this Agreement, the Registration Rights Agreement, and any other documents or agreements executed in
connection with the transactions contemplated hereunder. 
 ARTICLE 2. 
 PURCHASE AND SALE 
 2.1. Closing. Subject to the terms and conditions set forth
in this Agreement, at the Closing the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company, the Shares representing the Investor’s Investment Amount. The Closing shall take place on the Closing Date at
the offices of Bryan Cave LLP, 1290 Avenue of the Americas, New York, NY 10104 or at such other location as the parties may agree. 
 2.2.
Closing Deliveries. (a) At the Closing, the Company shall deliver or cause to be delivered to the Investor the following (the “Company Deliverables”): 
 (i) evidence of instructions to American Stock Transfer & Trust Company, transfer agent to the Company (the “Transfer Agent”)
authorizing the Transfer Agent to issue a certificate evidencing a number of Shares equal to the Investor’s Investment Amount divided by the Per Share Purchase Price, registered in the name of the Investor; and 
  

 3 

 (ii) the Registration Rights Agreement, duly executed by the Company. 
 (b) At the Closing, the Investor shall deliver or cause to be delivered to the Company the following (the “Investor Deliverables”):

 (i) the Investment Amount, in United States dollars and in immediately available funds, by wire transfer to an account designated in
writing by the Company for such purpose; and 
 (ii) the Registration Rights Agreement, duly executed by the Investor. 
 ARTICLE 3. 
 REPRESENTATIONS AND WARRANTIES

 3.1. Representations and Warranties of the Company. The Company hereby makes the following representations and warranties to the
Investor: 
 (a) Organization and Qualification. The Company is duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company is not
in violation of any of the provisions of its certificate of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct its business and is in good standing as a foreign corporation or other entity
(as applicable) in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except for such jurisdictions where the failure to be so qualified or in good standing, as the case may
be, would not have a Material Adverse Effect. 
 (b) Authorization; Enforcement. The Company has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations thereunder. The execution and delivery of each of the Transaction Documents by the Company and
the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company in connection therewith. Each Transaction Document has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other
equitable principles of general application. 
 (c) Issuance of the Shares. The Shares have been duly authorized and, when issued and
paid for in accordance with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable and free and clear of all Liens. The Company has reserved from its duly authorized capital stock the shares of Common Stock issuable
pursuant to this Agreement in order to issue the Shares. 
  

 4 

 (d) Certain Registration Matters. Assuming the accuracy of the Investor’s representations and
warranties set forth in Section 3.2(b)-(e), no registration under the Securities Act is required for the offer and sale of the Shares by the Company to the Investor under the Transaction Documents. 
 (e) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated thereby do not and will not result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court, regulatory body, administrative agency, governmental authority or other
authority to which the Company is subject (including federal and state securities laws and regulations). 
 3.2. Representations and
Warranties of the Investor. The Investor hereby represents and warrants to the Company as follows: 
 (a) Authority. The Investor has
the requisite legal capacity to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out his obligations thereunder. Each of this Agreement and the Registration Rights Agreement has been (or
upon delivery will have been) duly executed by the Investor, and when delivered by the Investor in accordance with the terms hereof, will constitute the valid and legally binding obligation of the Investor, enforceable against him in accordance with
its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by
other equitable principles of general application. 
 (b) No Conflicts. The execution, delivery and performance of the Transaction
Documents by the Investor and the consummation by the Investor of the transactions contemplated thereby do not and will not (i) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, debt or other instrument or other understanding to which the Investor is a party
or by which any property or asset of the Investor is bound or affected, or (ii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the
Investor is subject (including federal and state securities laws and regulations), or by which any property or asset of the Investor is bound or affected. 
 (c) Investment Intent. The Investor is acquiring the Shares as principal for his own account for investment purposes only and not with a view to or for distributing or reselling such Shares or any part thereof,
without prejudice, however, to the Investor’s right at all times to sell or otherwise dispose of all or any part of such Shares in compliance with applicable federal and state securities laws. Subject to the immediately preceding sentence,
nothing contained herein shall be deemed a representation or warranty by the Investor to hold the Shares for any period of time. The Investor does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of
the Shares. Nothing contained in this Section 3.2(c) shall in any way affect the Investor’s rights under the Registration Rights Agreement. 
  

 5 

 (d) Investor Status. At the time the Investor was offered the Shares, he was, and at the date
hereof he is, an “accredited investor” as defined in Rule 501(a) under the Securities Act. The Investor is not a registered broker-dealer under Section 15 of the Exchange Act. 
 (e) General Solicitation. The Investor is not purchasing the Shares as a result of any advertisement, article, notice or other communication
regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement. 
 (f) Access to Information. The Investor acknowledges that he has reviewed the disclosure materials provided by the Company and has been afforded
(i) the opportunity to ask such questions as he has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Shares and the merits and risks of investing in the
Shares; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable him to evaluate his investment; and (iii) the opportunity to
obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. 
 (g) Certain Trading Activities. Except for warrant exercises referenced in that certain Warrant Exercise Agreement, dated as of the date hereof,
between the Investor and the company, the Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with the Investor, engaged in any transactions in the securities of the Company (including,
without limitations, any Short Sales involving the Company’s securities) since March 15, 2006. The Investor covenants that neither he nor any Person acting on his behalf or pursuant to any understanding with him will engage in any
transactions in the securities of the Company (including Short Sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed. The Company agrees to file a Form 8-K with the Commission regarding this Agreement
as and when required. 
 (h) Independent Investment Decision. The Investor has independently evaluated the merits of his decision to
purchase Shares pursuant to the Transaction Documents, and the Investor confirms that he has not relied on the advice of the Company’s business advisors and/or legal counsel in making such decision. 
 (i) Investment Amount. The Investment Amount shall be delivered to the Company, free and clear of all Liens. 
 ARTICLE 4. 
 OTHER AGREEMENTS OF THE PARTIES

 4.1. (a) Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the
Shares other than pursuant to an effective registration statement, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities Act. 
  

 6 

 (b) Certificates evidencing the Shares will contain the following legend, until such time as they are not
required under Section 4.1(c): 
 THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. 
 (c)
Certificates evidencing Shares shall not contain any legend (including the legend set forth in Section 4.1(b)): (i) following a sale, transfer or other disposition of such Shares pursuant to an effective registration statement (including a
Registration Statement), or (ii) following a sale or transfer of such Shares pursuant to Rule 144 (assuming the transferee is not an Affiliate of the Company), (iii) while such Shares are eligible for sale or transfer under Rule 144(k), or
(iv) if the transferor provides to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that no legend is required for purposes of
the Securities Act. 
 4.2. Furnishing of Information. After the Compliance Date, as long as the Investor owns the Shares, the Company
covenants to use all commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange
Act. After the Compliance Date, as long as the Investor owns Shares, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Investor and make publicly available in accordance with Rule
144(c)(2) such information as is required under Rule 144(c)(2) for the Investor to sell the Shares under Rule 144. 
 4.3. Sale Back
Option. This Agreement is being entered into pursuant to the terms of that certain Memorandum of Understanding dated July 12, 2006 for claims set forth in In re: DHB Industries, Inc. Class Action Litigation, Case No. CV-05-4296
(E.D.N.Y.) and In re DHB Industries, Inc. Derivative Litigation, Case No. CV-05-4345 (E.D.N.Y.) (the “MOU”). In the event of the issuance of a final, nonappealable order by the New York Courts denying approval 

  

 7 

 
of the MOU (such date, the “Rejection Date”) then for a period of ninety (90) days after the Rejection Date, the Investor shall have
the option to put some or all of the Shares back to the Company at the Per Share Purchase Price on the same terms and conditions set forth in this Agreement. The Company’s obligations under this Section 4.3 shall be contingent upon the
return of settlement funds deposited with the escrow agent pursuant to the terms of Section 8 of the MOU. In the event that the Investor invokes his option prior to the return of the settlement funds to the Company, the Company shall cause such
amount as is owed to the Investor to be paid to the Investor directly from escrow as soon as the funds are permitted to be released from escrow. 
 4.4. Use of Proceeds. The Company shall use the Investment Amount to fund a portion of the settlement set forth in the MOU. Such funds shall be placed in an escrow account pursuant to the terms of the MOU until released in accordance
with the terms of the MOU. 
 4.5. Short Sales. Investor covenants and agrees not to engage in any Short Sales of the Shares for a
period of one (1) year after the Closing Date. 
 4.6. Material Non-Public Information. Investor hereby acknowledges that he is
aware that the United States securities laws prohibit any person who has material non-public information with respect to a public company from purchasing or selling securities of such company, or from communicating such information to any other
person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities. Investor further hereby acknowledges that he is in possession of material non-public information for purposes of the
United States securities laws, including, without limitation, as a result of his service as an officer and director of the Company. 
 ARTICLE
5. 
 MISCELLANEOUS 
 5.1. Fees
and Expenses. The Parties acknowledge that this transaction is being entered into in connection with the settlement of class and derivative actions in which the Investor is a party. Accordingly, the reasonable legal fees and expenses incurred by
the Investor incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents are subject to advancement pursuant to the Company’s bylaws, certificate of incorporation, and governing corporate law and
possible repayment pursuant to the undertaking required by those provisions. The Company shall pay all stamp and other taxes and duties levied in connection with the sale of the Shares. 
 5.2. Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the
parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules. 
 5.3. Notices. Any and all notices or other communications or deliveries required or permitted to be
provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via 

  

 8 

 
facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the facsimile number specified in this Section prior
to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a
Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. The address for such notices and communications shall be as follows: 
  

					
	 If to the Company:
	  	DHB Industries, Inc.
		  	2102 SW 2nd Street
		  	Pompano Beach, FL 33069
		  	Facsimile:	  	954-630-9225
		  	Attention:	  	Chief Executive Officer
		
	 With a copy to:
	  	Bryan Cave LLP
		  	1290 Avenue of the Americas
		  	New York, NY 10104
		  	Facsimile:	  	212-541-4630
		  	Attention:	  	Kenneth Henderson
		
	 If to the Investor:
	  	David H. Brooks
		  	20 Red Ground Road
		  	Old Westbury, NY 11568
		  	Facsimile:	  	516-626-9177
		
	 With a copy to:
	  	Milbank, Tweed, Hadley & McCloy LLP
		  	1 Chase Manhattan Plaza
		  	New York, New York 10005
		  	Facsimile:	  	212-530-5219
		  	Attention:	  	George S. Canellos

 or such other address as may be designated in writing hereafter, in the same manner, by such Person. 

5.4. Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written instrument
signed by the Company and the Investor. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of
any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. 
 5.5. Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or
affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 

  

 9 

 
This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party
by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents. 
 5.6. Successors and Assigns.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. No party to this Agreement may assign this Agreement or any rights or obligations hereunder without the prior written consent of
the other party hereto. 
 5.7. No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and
their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 
 5.8. Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of the any of the Transaction Documents), and hereby irrevocably waives,
and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any Proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. If either party shall commence a Proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such Proceeding. 
 5.9. Survival. The representations,
warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Shares. 
 5.10. Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof. 
  

 10 

 5.11. Severability. If any provision of this Agreement is held to be invalid or unenforceable in
any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 5.12. Replacement
of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new
certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Shares. If a replacement certificate or instrument evidencing any Shares is requested due to a
mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement. 
 5.13. Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Investor and the Company will be entitled to specific performance under
the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any action for
specific performance of any such obligation the defense that a remedy at law would be adequate. 
 [Signature Page to Follow] 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated above. 
  

			
	DHB INDUSTRIES, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	
		
		 	  

		 	DAVID H. BROOKS

 [Signature Page to Securities Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}]]